PROVIDER PROFILE · NPI 1538191846

Mark LiskaM.D.

DermatologyNorth Falmouth, MAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$3K

Distinct drugs

Brand share

48.8%

Top prescribed drugs

Triamcinolone Acetonide27 claims

Betamethasone/Propylene Glyc26 claims

Fluorouracil16 claims

Valacyclovir Hcl15 claims

QUALITY · MIPS · 2024

Final MIPS score

86.6

Quality

84.3

Cost

74.5

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.49%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$80

Payment records

By payment type

Food and Beverage$60

Grant$20

Top paying entities

Food and Beverage$60

Grant$20

REFERRAL NETWORK

Where Mark Liska's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 78 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Cohen Dermatopathology, P.C. Clinical Laboratory · Needham, MA	858	1,351
CAPE COD HOSPITAL INC	783	1,750
FALMOUTH HOSPITAL ASSOCIATION INC	584	1,020
Quest Diagnostics Massachusetts Llc Clinical Laboratory · Marlborough, MA	132	187
Mohammad Nourmohammadi Diagnostic Radiology · Los Angeles, CA	117	154
Robb Hoehlein Diagnostic Radiology · Falmouth, MA	86	123
URBACH, DAVID	79	142
Michael Fishbein Diagnostic Radiology · Falmouth, MA	75	105
Ethel Baylor Podiatry · Falmouth, MA	73	104
NPI 1376594648	69	156
Richard Armstrong Podiatry · Falmouth, MA	67	113
CHRISTMAN, GEORGE	67	166

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history